Jci_page_head_homepage_01 Jci_page_head_homepage_02
Silvana Obici, Zhaohui Feng, Jianzhen Tan, LiSen Liu, George Karkanias, Luciano Rossetti
Published in Volume 108, Issue 7
J Clin Invest. 2001; 108(7):1079–1085 doi:10.1172/JCI12954
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Schematic representation of the experimental design. (a) Surgical implantation of intracerebroventricular cannulae was performed on day 1 (∼3 weeks before the in vivo study). Full recovery of body weight and food intake was achieved by day 7. Surgical implantation of intravenous catheters and of osmotic minipumps (for intracerebroventricular [ICV] infusions) was performed on day 14. Intracerebroventricular infusions were continued for 7 days. Finally, on day 21, body composition and insulin action were estimated. (b) A bolus of tritiated water was given intravenously 3 hours before starting the tritiated glucose infusion. At t = 0 a primed-continuous infusion of labeled glucose was initiated and maintained for the remainder of the 4-hour study. Pancreatic-insulin clamp study was initiated at t = 120 minutes and lasted 120 minutes.